LDN-193189
| 英文名 | LDN-193189 | CAS号 | 1062368-24-4 |
| 试剂别名 |
4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline;LDN-193189;4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;4-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]Quinoline;6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine;DM-3189;LDN 193189;LDN193189 (LD-N193189,DM3189);4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline hydrochloride DM-3189;DM 3189;UNII-W69H5YQU9O;4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;LDN193189;LDN193189(DM3189);LDN-193189, >=98%;LDN193189
LDN193189 HCl;4-{6-[4-(piperazin-1-yl)phenyl]pyrazolo[;LDN-193189, 98%, a selective BMP signaling inhibitor
|
分子式 | C25H22N6 |
| 产品编号 | APEA8324 | 分子量 | 406.48 |
| MDL号 | MFCD17392570 |
| 产品名称： | LDN-193189 |
| 英文名称： | LDN-193189 |
| 英文别名： | 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline;LDN-193189;4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;4-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]Quinoline;6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine;DM-3189;LDN 193189;LDN193189 (LD-N193189,DM3189);4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline hydrochloride DM-3189;DM 3189;UNII-W69H5YQU9O;4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;LDN193189;LDN193189(DM3189);LDN-193189, >=98%;LDN193189 LDN193189 HCl;4-{6-[4-(piperazin-1-yl)phenyl]pyrazolo[;LDN-193189, 98%, a selective BMP signaling inhibitor |
| 中文别名： | 4-(6-(4-(哌嗪-1-基)苯基)吡唑并[1,5-a]嘧啶-3-基)喹啉;4-[6-(4-(哌嗪-1-基)苯基]吡唑并[1,5-A]嘧啶-3-基)喹啉;LDN193189 抑制剂;厚朴酚;木兰醇;4-[6-(4-(哌嗪-1-基)苯基]吡唑并[1,5-a]嘧啶-3-基)喹啉;LDN-193189, 一种选择性BMP信号转导抑制剂 |
| CAS No.： | 1062368-24-4 |
| 分子式： | C25H22N6 |
| 分子量： | 406.48 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
